Samsung BioLogics said it would construct a new facility in South Korea that will double its production capacity and make it the world’s largest contract drug maker.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 11/27/2015 - 4:00am
Samsung BioLogics said it would construct a new facility in South Korea that will double its production capacity and make it the world’s largest contract drug maker.